产品名称
SUPELCOSIL™ LC-18-DB Supelguard 柱芯, 5 μm particle size, L × I.D. 2 cm × 4 mm
packaging
pkg of 1 kit
technique(s)
HPLC: suitable
L × I.D.
2 cm × 4 mm
matrix active group
C18 (octadecyl) phase
particle size
5 μm
application(s)
food and beverages
separation technique
reversed phase
Quality Level
Other Notes
套装包括一个保护柱芯、一个独立式柱套、一根连接管、2 个接头螺母与密封垫圈。
General description
SUPELCOSIL™ LC-18-DB Supelguard Cartridges [5 μm particle size, L × I.D. 2 cm × 4 mm] contain a SUPELCOSIL packing, in a 2 cm stainless steel body, enclosed by polyether ether ketone (PEEK) encapsulated stainless steel frits (2 μm porosity). A Supelguard kit (one cartridge, a stand-alone holder, tubing, and 2 nuts and ferrules) enables one to use the cartridge with any analytical column. A direct-connect guard cartridge holder can directly connect a Supelguard cartridge to a Supelco analytical column. 3.0 mm cartridges are available in packs of two only-purchase a stand-alone or modular holder separately. Low volume 3.0 mm ID cartridges are a good choice for protecting an analytical column containing 3 μm particles.
Legal Information
SUPELCOSIL is a trademark of Sigma-Aldrich Co. LLC
存储类别
13 - Non Combustible Solids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
S L Bramer et al.
Journal of pharmaceutical and biomedical analysis, 26(4), 637-650 (2001-08-23)
An LC/MS/MS method for the simultaneous determination of cilostazol, a quinolinone derivative, and three active metabolites, OPC-13015, OPC-13213, and OPC-13217, in human plasma was developed and validated. Cilostazol, its metabolites, and the internal standard, OPC-3930 were extracted from human plasma
O Majid et al.
Therapeutic drug monitoring, 23(2), 163-168 (2001-04-11)
Recipients of organ transplants remain particularly dependent on prednisolone as part of their maintenance immunosuppression. Despite this, the pharmacokinetics of prednisolone have never been fully characterized in these patients, and consequently dosing remains empirical. Accurate monitoring of prednisolone, its primary
Xinghua Sun et al.
Anticancer research, 25(1A), 59-62 (2005-04-09)
A rapid, sensitive and specific high-performance liquid chromatographic (HPLC) method for the separation and quantification of L-methionine in plasma has been developed. After derivatization of plasma amino acids with o-phthalaldehyde (OPA), a 50 microl sample was loaded on a reversed-phase
E Terjéki et al.
Journal of pharmaceutical and biomedical analysis, 24(5-6), 913-920 (2001-03-15)
RGH-1756 (1-(2-methoxy-phenyl)-4-(4-[4-(6-imidazo[2,1-b]-thiazolyl)-phenoxy]-butyl)-piperazine dimethansulphonate) is a novel atypical antipsychotic candidate of Gedeon Richter Ltd. A new HPLC method has been developed and validated for the quantitative determination of RGH-1756 in dog and rat plasma. The compound and the internal standard are
P K Kunicki
Journal of chromatography. B, Biomedical sciences and applications, 755(1-2), 331-335 (2001-06-08)
A HPLC-UV determination of loratadine in human plasma is presented. After simple liquid-liquid extraction with 2-methylbutane-hexane (2:1) and evaporation of organic phase the compounds were re-dissolved in 0.01 M HCl, evaporated again and finally separated on a Supelcosil LC-18-DB column.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持